Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Vaccines
Filter     Order     Display # 
Date Item Title
04 Aug 2006 Immutep Announces That ImmuFact IMP321 Has Entered a Phase I Chemoimmunotherapy Trial in Breast Cancer
02 Aug 2006 AVANT's CholeraGarde(R) Vaccine Development Program Receives Further Funding from the Gates Foundation; New Support Follows Successful Phase 2 Clinical Trials
01 Aug 2006 The Immune Response Corporation Receives Approval for Expansion of Phase II Trial in France for Investigative HIV Immunotherapy IR103
01 Aug 2006 CytRx Reports Successful Completion of Phase I HIV Vaccine Clinical Trial; Data Indicates Favorable Safety and Immune Responses; ABL and UMMS Investigators Expect to File Final Trial Results with the FDA in August
31 Jul 2006 Novavax Succeeds in Making Vaccine to Protect Against New Mutation of Avian Influenza
31 Jul 2006 MedImmune Submits Refrigerator-Stable Formulation of FluMist® to FDA for Approval in Younger Children
31 Jul 2006 Acambis announces encouraging safety and immunogenicity results from Phase 2 study of MVA3000 smallpox vaccine
29 Jul 2006 GARDASIL(R), Merck's Cervical Cancer Vaccine, Receives Positive Opinion from the European Medicines Agency
28 Jul 2006 Data Safety Monitoring Board Recommends Continuation of MyVax(R) Personalized Immunotherapy Phase 3 Trial After Second Interim Analysis
26 Jul 2006 GSK reports significant advance in H5N1 pandemic flu vaccine programme
26 Jul 2006 FDA Has Granted Pharmexa Orphan Drug Status for GV1001 in Pancreatic Cancer
21 Jul 2006 Greer Announces Launch of Phase IIB Clinical Trials for Sublingual-Oral Immunotherapy for Short Ragweed Allergy
20 Jul 2006 Biomira Stimuvax(R) (L-BLP25) Prostate Cancer Study Results Published
19 Jul 2006 OncoVAX® Vaccine Designed to Prevent Recurrence in Stage II Colon Cancer Patients Following Surgical Tumor Resection
19 Jul 2006 MedImmune Receives Complete Response Letter From FDA for New Formulation of FluMist®
19 Jul 2006 Novavax Inc. (NVAX) Receives Positive Results From Pre-Clinical Studies Of Influenza Vaccines
18 Jul 2006 Crucell Announces Suspension of Aerugen(R) Clinical Development
14 Jul 2006 SIGA Announces Successful Completion Of Its Smallpox Drug Candidate’s Initial Human Safety Trial
12 Jul 2006 Latest data show GlaxoSmithKline’s proprietary adjuvant system for Cervarix™ induces a stronger and more sustained immune response than a conventional adjuvant formulation
12 Jul 2006 CSC’S DVC Begins Phase 2 Clinical Trial For Plague Vaccine Candidate
10 Jul 2006 Antigenics Announces Expansion of its License and Supply Agreement With GlaxoSmithKline Biologicals for QS-21 Stimulon Adjuvant
06 Jul 2006 Baxter Initiates Clinical Study With Cell-Based Candidate H5N1 Pandemic Vaccine
05 Jul 2006 Cell Genesys Announces Publication of Encouraging Phase 1/2 Clinical Results For GVAX(R) Immunotherapy for Prostate Cancer in Early Stage Patients Before Receiving Hormone Therap
05 Jul 2006 Favrille Publishes Data From Phase 2 Clinical Trial Demonstrating Biologic Activity of Lead Product Candidate FavId in Indolent Non-Hodgkin's Lymphoma
05 Jul 2006 Epeius Biotechnologies Initiates Tri-Rex Vaccination Protocols For Breast Cancer
30 Jun 2006 Dendreon Announces Publication of Pivotal Phase 3 Study Highlighting Survival Benefit and Safety Profile of PROVENGE in Men with Advanced Prostate Cancer
29 Jun 2006 Therion Reports Results of Phase 3 PANVAC-VF Trial and Announces Plans for Company Sale
22 Jun 2006 Celtic Pharma Reports Preliminary Results of Phase 2 Clinical Trials With TA-CD, Cocaine Addiction Vaccine
21 Jun 2006 Pharmexa granted orphan drug designation for GV1001 in Europe
21 Jun 2006 Mymetics Announces Encouraging Preclinical Results of the Company's HIV Vaccine Candidate in Non-Human Primates
20 Jun 2006 Viral Genetics Announces Results of South African Study of VGV-1
20 Jun 2006 The Immune Response Corporation Completes First Stage of Enrollment and Receives Approval for Expansion of Phase II Trial for Investigative HIV Immunotherapy IR103
20 Jun 2006 Sinovac Announces Pandemic Influenza Vaccine Phase I Clinical Trial Preliminary Results
16 Jun 2006 Bio-Bridge Announces Favorable Safety and Immunogenicity Results From Pre-clinical Study of Oral HIV Vaccine; Animal Studies Suggest Vaccine is Safe and Efficacious in Treatment of HIV
15 Jun 2006 ViRexx Announces the Initiation of a Phase I Clinical Study of HepaVaxx B
15 Jun 2006 Phase II application for GV1001 in lung cancer submitted
15 Jun 2006 Favrille Announces FDA Allowance of Investigational New Drug Application for FAV-201, a Patient-Specific Immunotherapy for T-Cell Lymphoma
15 Jun 2006 Nventa Announces Positive HspE7 Data From NCI-Sponsored Clinical Trial In HIV-Positive Patients
15 Jun 2006 MedImmune and National Institutes of Health Begin Clinical Testing of a Live, Attenuated Intranasal Vaccine Against an H5N1 Avian Influenza Virus
13 Jun 2006 FDA Grants Fast Track Status to MyVax(R) Personalized Immunotherapy for Follicular Non-Hodgkin's Lymphoma
13 Jun 2006 European Journal Of Neurology Publishes MBP8298 Phase II And Long-Term Follow-Up Data
13 Jun 2006 Novartis expands late-stage vaccines pipeline with novel vaccine for prevention of Japanese Encephalitis virus infections
12 Jun 2006 Hemispherx Biopharma Advances Influenza Vaccine/Immunopotentiation Clinical Trials Designed to Increase Vaccine Dosage Supply and Increase Cross-Protection
09 Jun 2006 FDA Approves Merck's GARDASIL®, the World's First and Only Cervical Cancer Vaccine
08 Jun 2006 GlobeImmune Initiates Phase 2 Trial for Pancreas Cancer
08 Jun 2006 Antigenics Announces Results From In-Depth Analysis of Phase 3 Data of Oncophage in Kidney Cancer and Provides Regulatory Update
07 Jun 2006 Dendreon Announces Publication of Research Showing Promising Activity of PROVENGE in Combination with Avastin in Patients with Recurrent Early Stage Prostate Cancer
07 Jun 2006 Dynavax Announces Completion of Enrollment in TOLAMBA(TM) Ragweed Allergy Trial
07 Jun 2006 Protherics Acquires Novel Vaccine Adjuvant And Prepares For Phase 2 Study Of Its Angiotensin Vaccine
07 Jun 2006 Oxford Biomedica Reports New Encouraging Phase II Results With Trovax And Progress In The Development Plan
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 451 - 500 of 601

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Toll-Like Receptor (TLR) Agonists & Antagonists

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics